Association of Inflammatory and Liver Markers with Cardiometabolic Risk Factors in Patients with Depression
- 7 Downloads
Metabolic syndrome (MS) is found to be more prevalent in patients with psychiatric disorders including depression. This study aimed to assess the association of inflammatory and liver markers with cardiometabolic risk factors in patients with Depressive disorders. Prevalence of MS by using Modified NCEP ATP-III Criteria and liver enzymes and CRP were assessed in 382 patients with depressive disorders. MS prevalence was 27.7% and lower HDL level was the commonest metabolic abnormality. ALT, GGT, and CRP levels were positively correlated with weight and BMI. ALT, GGT, and CRP levels were significantly greater in patients with abnormal waist circumference, triglyceride levels and raised blood pressure, compared to patients with normal indices. Such association was not found with abnormal HDL cholesterol and hyperglycemia. Levels of GGT and CRP were significantly greater in patients with MS compared to patients without MS and CRP was significant predictor for MS. To conclude, one-fourth of depressed patients had MS. MS and metabolic abnormalities were associated with inflammatory marker and liver enzymes. Patients with depression should be regularly evaluated for cardiovascular risk factors, liver enzymes, and inflammatory markers.
KeywordsMetabolic syndrome Liver enzymes Inflammatory markers Depression India
This project has received intramural grant from All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan.
Compliance with Ethical Standards
Conflict of interest
The authors report no conflict of interest.
- 3.Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339–47.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med. 2008;25:523–9.CrossRefPubMedGoogle Scholar
- 10.World Health Organization. The ICD-10 classification of mental and behavioural disorders—clinical descriptions and diagnostic guidelines. Geneva: WHO; 1992.Google Scholar
- 14.Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of obesity. Circulation. 2009;120:1640–5.CrossRefPubMedGoogle Scholar
- 17.Aggarwal M, Grover S, Chakrabarti S, Dutt A, Avasthi A, Kulhara P. Prevalence of metabolic syndrome in depression. J Ment Health Hum Behav. 2012;17:15–24.Google Scholar
- 19.Rathi A, Jhanjee A, Bhatia MS. A study of the prevalence, socio-demographic and clinical correlates of metabolic syndrome (MS) in drug-naive patients of anxiety and depressive disorders. Delhi Psychiatry J. 2013;16:7–14.Google Scholar